We are live on
!
Find out more
MCM
Monarch Capital Management Portfolio holdings
AUM
$436M
1-Year Est. Return
26.61%
This Fund
S&P 500
This Quarter
Est. Return
+2.47%
1 Year Est. Return
+26.61%
3 Year Est. Return
+65.03%
5 Year Est. Return
+87.16%
10 Year Est. Return
+267.35%
AUM
$264M
AUM Growth
-$9.1M
(-3.3%)
Cap. Flow
-$14.6M
Cap. Flow
% of AUM
-5.54%
Top 10 Holdings %
Top 10 Hldgs %
31.97%
Holding
98
New
2
Increased
13
Reduced
60
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kroger
KR
|
+$1.11M |
| 2 |
Target
TGT
|
+$553K |
| 3 |
Zimmer Biomet
ZBH
|
+$361K |
| 4 |
Constellation Brands
STZ
|
+$218K |
| 5 |
Gilead Sciences
GILD
|
+$192K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$3.4M |
| 2 |
Merck
MRK
|
+$1.74M |
| 3 |
Northrop Grumman
NOC
|
+$1.21M |
| 4 |
McDonald's
MCD
|
+$1.11M |
| 5 |
ExxonMobil
XOM
|
+$999K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.97% |
| 2 | Industrials | 14.68% |
| 3 | Consumer Staples | 13.23% |
| 4 | Technology | 12.83% |
| 5 | Financials | 12.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Merck
MRK
$322B
| $9.94M | 3.76% |
162,519
-28,524
| -15% | -$1.74M |
|
|
2
McDonald's
MCD
$192B
| $9.55M | 3.62% |
62,375
-7,683
| -11% | -$1.11M |
|
3
Lakeland Financial Corp
LKFN
$1.56B
| $9.54M | 3.61% |
207,833
-8,531
| -4% | -$380K |
|
4
Johnson & Johnson
JNJ
$618B
| $9.03M | 3.42% |
68,280
-1,801
| -3% | -$230K |
|
|
WBA
5
DELISTED
Walgreens Boots Alliance
WBA
| $8.97M | 3.4% |
114,597
-285
| -0.2% | -$23.5K |
|
6
Franklin Electric
FELE
$4.63B
| $7.79M | 2.95% |
188,036
-13,873
| -7% | -$557K |
|
7
Medtronic
MDT
$109B
| $7.66M | 2.9% |
86,273
-1,875
| -2% | -$158K |
|
8
Walmart Inc
WMT
$885B
| $7.52M | 2.85% |
298,224
-13,920
| -4% | -$353K |
|
9
Home Depot
HD
$331B
| $7.51M | 2.84% |
48,989
-2,520
| -5% | -$387K |
|
|
10
ExxonMobil
XOM
$644B
| $6.94M | 2.63% |
85,976
-12,216
| -12% | -$999K |
|
11
Coca-Cola
KO
$377B
| $6.78M | 2.57% |
151,137
-3,972
| -3% | -$176K |
|
12
Microsoft
MSFT
$3.45T
| $6.77M | 2.56% |
98,194
-6,483
| -6% | -$445K |
|
13
Procter & Gamble
PG
$336B
| $6.73M | 2.55% |
77,202
-1,876
| -2% | -$165K |
|
14
Emerson Electric
EMR
$83.9B
| $6.24M | 2.36% |
104,690
-3,584
| -3% | -$213K |
|
15
3M
MMM
$90.9B
| $6.24M | 2.36% |
35,820
-2,051
| -5% | -$343K |
|
16
Automatic Data Processing
ADP
$106B
| $5.9M | 2.23% |
57,570
+719
| +1% | +$72.8K |
|
17
Intel
INTC
$455B
| $5.88M | 2.23% |
174,357
-1,840
| -1% | -$65.8K |
|
18
RTX Corp
RTX
$290B
| $5.66M | 2.14% |
73,698
-588
| -0.8% | -$44K |
|
19
Cisco
CSCO
$457B
| $5.54M | 2.1% |
177,006
-6,300
| -3% | -$205K |
|
20
AbbVie
ABBV
$443B
| $5.27M | 2% |
72,718
-3,020
| -4% | -$203K |
|
21
Abbott
ABT
$183B
| $5.18M | 1.96% |
106,645
-3,335
| -3% | -$151K |
|
22
US Bancorp
USB
$98.2B
| $5.18M | 1.96% |
99,723
-200
| -0.2% | -$10.3K |
|
|
23
Zimmer Biomet
ZBH
$18.2B
| $4.92M | 1.86% |
39,462
+3,048
| +8% | +$361K |
|
24
Sysco
SYY
$40.8B
| $4.59M | 1.74% |
91,122
-4,110
| -4% | -$219K |
|
25
Accenture
ACN
$102B
| $4.56M | 1.73% |
36,843
+100
| +0.3% | +$12.2K |
|
Similar funds
VDBMI
ACG
VIM
TECP
SCP
SWG
VBA
BCM
Monarch Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Monarch Capital Management held 98 positions worth $264M, down 3.3% from $273M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Monarch Capital Management withdrew a net $14.6M in Q2 2017, closing 4 positions and reducing 60 holdings. Its most notable exit was Northrop Grumman, an estimated $1.21M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, Monarch Capital Management opened a new position in Kroger worth $914K.
- Monarch Capital Management's largest Q2 2017 buy was Kroger: 39,200 shares worth $914K.
- Monarch Capital Management added most to Target in Q2 2017, an estimated $553K increase.
- Monarch Capital Management's biggest Q2 2017 reduction was Philip Morris, cutting an estimated $3.4M.
- Monarch Capital Management fully exited Northrop Grumman in Q2 2017, selling an estimated $1.21M.
- Monarch Capital Management's ten largest holdings make up 32% of its $264M portfolio in Q2 2017.
- Monarch Capital Management opened 2 new positions and closed 4 in Q2 2017.
- Monarch Capital Management's portfolio value fell 3.3% quarter-over-quarter to $264M.
Based on Monarch Capital Management's 13F filing for Q2 2017, filed 26 Jul 2017.